BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kapadia SN, Johnson P, Schackman BR, Bao Y. Hepatitis C Treatment Uptake by New Prescribers After the Introduction of Direct Acting Antivirals. J Gen Intern Med 2020;35:975-7. [PMID: 31325131 DOI: 10.1007/s11606-019-05200-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kapadia SN, Johnson P, Marks KM, Schackman BR, Bao Y. Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era. Med Care 2021;59:795-800. [PMID: 34081676 DOI: 10.1097/MLR.0000000000001573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Agi E, Asghari S, Namvar A, Khairkhah N, Naderi N, Anvar A, Azizi Saraji A, Bolhassani A; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Molecular Study of Occult Hepatitis C Infection among Iranian Hemophilia Patients Treated with Direct-acting Antiviral Agents. JoMMID 2020;8:1-6. [DOI: 10.29252/jommid.8.1.1] [Reference Citation Analysis]